Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen

Pediatric Pulmonology

Volumn 26, Issue 2, 1998, Pages 89-96

  Johansen, Helle Krogh ^a   Kovesi, Thomas A ^b,c   Koch, Christian ^c   Corey, Mary ^c   Høiby, Niels ^a   Levison, Henry ^c  

^a Rigshospitalet   (Denmark)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Burkholderia cepacia; Cystic fibrosis; Epidemiology; Mutations; Natural history; Nutritional status; Pseudomonas aeruginosa; Treatment strategies

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BURKHOLDERIA CEPACIA; CANADA; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DENMARK; FEMALE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; BURKHOLDERIA INFECTIONS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DENMARK; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LINEAR MODELS; MALE; ONTARIO; PREVALENCE; PSEUDOMONAS INFECTIONS; RISK FACTORS; SEX DISTRIBUTION; URBAN POPULATION;

EID: 0031875165     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199808)26:2<89::AID-PPUL3>3.0.CO;2-C     Document Type: Article

References (42)

1. Pedersen SS. Lung Infection with alginate-producing, mucoid Pseudomonus aeruginosa in cystic fibrosis. APMIS. 1992; 100(lSuppl 28):5-79.
2. Pedersen SS, Koch C, Høiby N, Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis center. J Antimicrob Chemother. 1986; 17:505-516.
3. Isles A, MacLusky I, Corey M, Gold R, Prober C, Flemming P, Levison H. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem. J Pediatr. 1984; 104:206-210.
4. Høiby N, Pedersen SS. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand. 1989; 78:395-404.
5. Wolz C, Kiosz G, Ogle JW, Vasil ML, Schaad U, Botzenhart K, Döring G. Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis: Use of a DNA probe. Epidemiol Infect. 1989; 102:205-214.
6. Tümmler B, Koopmann U, Grothues D, Weissbrodt H, Steinkamp G, Vonderhardt H. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients. J Clin Microbiol. 1991; 29: 1265-1267.
7. Thomassen MJ, Demko CA, Doershuk CF, Stern RC, Klinger JD. Pseudomonas cepacia: Decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis. 1986; 134:669-671.
8. Lipuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between persons with cystic fibrosis. Lancet 1990; 336:1094-1096.
9. Pegues DA, Carson LA, Tablan OC, Fitzsimmons SC, Roman SB, Miller JM, Jarvis WR, and the Summer Camp Study Group. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. J Pediatr. 1994; 124:694-702.
10. Govan JRW, Brown PH, Maddison J, Doherty C, Nelson JW, Dodd M, Greening AP, Webb AK. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993; 342:15-19.
11. Nir M, Johansen HK, Høiby N. Low incidence of pulmonary Pseudomonas cepacia infection in Danish cystic fibrosis patients. Acta Paediatr. 1992; 81:1042-1043.
12. Johansen HK, Nir M, Høiby N, Koch C, Schwartz M. Severity of cystic fibrosis in patients homozygous and heterozygous for Delta-F508 mutation. Lancet. 1991; 337:631-634.
13. Kubesch P, Dork T, Wulbrand U, Kalin N, Neumann T, Wulf B, Geerlings H, Weissbrodt H, Vonderhardt H, Tümmler B. Genetic determinants of airways colonization with Pseudomonas aeruginosa in cystic fibrosis. Lancet. 1993; 341:189-193.
14. Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, Forstner G. Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr. 1982; 100:857-862.
15. Kerem EM, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H, Tsui L-C, Durie P. The relation between genotype and phenotype in cystic fibrosis: Analysis of the most common mutation (Delta-F508). N Engl J Med. 1990; 323:1517-1522.
16. Fitzsimmons SC. The changing epidemiology ot cystic fibrosis. J Pediatr. 1993; 122:1-9.
17. Kerem EM, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr. 1990; 116: 714-719.
18. Polgar GE, Promadhat V. Pulmonary function testing in children: Techniques and standards. Philadelphia: W.B. Saunders, 1971.
19. Høiby N. Microbiology of lung infections in cystic fibrosis patients. Acta Paediatr Scand. 1982; 301(Suppl):33-54.
20. Høiby N, Friis B, Jensen K, Koch C, Møller NE, Støvring S, Szaff M. Antimicrobial chemotherapy in cystic fibrosis patients. Acta Paediatr Scand. 1982; 301(Suppl):75-100.
21. Høiby N, Koch C. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Thorax. 1990; 45:881-884.
22. Valerius NH, Koch C, Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet. 1991; 338:725-726.
23. Kopelman H, Durie P, Gaskin K, Weizman Z, Forstner G. Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. N Engl J Med. 1985; 312:329-334.
24. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988; 41: 583-591.
25. Høiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Pathol Microbiol Scand. 1977; 262(Suppl; Sect C):3-96.
26. Brauner A. Høiby N, Kjartansson J, Kühn I, Svenberg-Appelgren P, Wretlind B. Pseudomonas cepacia septicemia in burned patients; Report of two cases. Scand J Infect Dis. 1985; 17:63-66.
27. Høiby N, Collins MT, Espersen F, Hertz JB, Hoff GE, Schiøtz PO. Taxonomic application of crossed immunoelectrophoresis. Int J Syst Bacteriol. 1987; 37:229-240.
28. Høiby N. Epidemiologic investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand. 1974; 82(Sect B):541-550.
29. Høiby N. Cross reactions between Pseudomonas aeruginosa and thirty-six other bacterial species. Scand J Immunol. 1975; 4(Suppl 2):187-196.
30. Weng TR, Levison H. Standards of pulmonary function in children. Am Rev Respir Dis. 1969; 99:879-894.
31. Norusis MJ. SPSS/PC+ V2.0 Base Manual for the IBM PC/XT/ AT and PS/2. Chicago: SPSS Inc., 1988.
32. Szaff M. Høiby N, Flensborg EW. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand. 1983; 72:651-657.
33. Frederiksen B, Lanng S, Koch C, Høiby N. Improved survival in the Danish-center treated cystic fibrosis patients: Results of aggressive treatment. Pediatr Pulmonol. 1996; 21:153-158.
34. Nielsen OH, Schiøtz PO. Cystic fibrosis in Denmark in the period 1945-1981. Evaluation of centralized treatment. Acta Paediatr Scand. 1982; 301(Suppl):107-119.
35. Pedersen SS, Jensen T, Høiby N, Koch C, Flensborg EW. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Acta Paediatr Scand. 1987; 76:955-961.
36. Corey M, Edwards L, Levison H. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr. 1997; 131:809-814.
37. Høiby N, Flensborg EW, Beck B, Friis B, Jacobsen L, Jacobsen SV. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis. 1977; 58:65-79.
38. Yabuuchi E, Kosako Y, Oyaizu H, Yano I, Hotta H, Hashimoto Y, Ezaki T, Arakawa M. Proposal of Burkholderia gen nov and transfer of 7 species of the genus pseudomonas homology Group-II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb nov. Microbiol Immunol. 1993; 36:1251-1275.
39. Pedersen SS, Koch C, Høiby N, Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis center. J Antimicrob Chemother. 1986; 17:505-516.
40. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992; 326:1187-1191.
41. Pressler T, Mansa B, Jensen T, Pedersen SS, Høiby N, Koch C. Increased IgG2 and IgG3 concentration is associated with advanced Pseudomonas aeruginosa infection and poor pulmonary function in cystic fibrosis. Acta Paediatr Scand. 1988; 77:576-582.
42. Brett MM, Ghoneim ATM, Littlewood JM. Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: A follow-up study. J Clin Microbiol. 1988; 26:1565-1570